A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

United States

Stanford Cancer Institute, Palo Alto, California

Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C., District of Columbia

University of Chicago Medical Center, Chicago, Illinois

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey